GSK-3039294

CAS No. 1819986-22-5

GSK-3039294( GSK3039294 )

Catalog No. M12802 CAS No. 1819986-22-5

GSK-3039294 is an orally available small molecule inhibitor of serum amyloid P component (SAP).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 Get Quote
5MG 65 Get Quote
10MG 110 Get Quote
25MG 200 Get Quote
50MG 335 Get Quote
100MG 500 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK-3039294
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-3039294 is an orally available small molecule inhibitor of serum amyloid P component (SAP).
  • Description
    GSK-3039294 is an orally available small molecule inhibitor of serum amyloid P component (SAP) binding to amyloid fibrils for the depletion of serum amyloid-P (SAP) component from the circulation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GSK3039294
  • Pathway
    Others
  • Target
    Amyloids
  • Recptor
    Amyloids
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    1819986-22-5
  • Formula Weight
    656.682
  • Molecular Formula
    C30H44N2O14
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 34 mg/mL 51.78 mM
  • SMILES
    O=C(N1[C@H](CCC1)C(OCOC(OC2CCOCC2)=O)=O)CCCCC(N3[C@H](CCC3)C(OCOC(OC4CCOCC4)=O)=O)=O
  • Chemical Name
    bis(((((tetrahydro-2H-pyran-4-yl)oxy)carbonyl)oxy)methyl) adipoyl(R)-di-D-prolinate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GSK-3039294

    GSK-3039294 is an orally available small molecule inhibitor of serum amyloid P component (SAP).

  • ALZ-801

    ALZ-801 is an orally available, valine-conjugated prodrug of tramiprosate, a small-molecule β-amyloid (Aβ) anti-oligomer and aggregation inhibitor for the treatment of Alzheimer's disease.

  • ARN-2966

    ARN-2966 is a potent, BBB penetrant post-transcriptional modulator of APP expression in transfected CHO cells that produce amyloid precursor protein (APP).